Capital Research Global Investors Sarepta Therapeutics, Inc. Transaction History

Capital Research Global Investors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $7,995 - $9,640	78 Added 0.01%	557,461 $67.6 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $31 Million - $45.8 Million	291,442 Added 109.59%	557,383 $63.8 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $31.3 Million - $41.5 Million	265,941 New	265,941 $36.7 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $196 Million - $253 Million	-2,542,191 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $146 Million - $204 Million	-2,208,578 Reduced 46.49%	2,542,191 $235 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $227 Million - $284 Million	-3,276,134 Reduced 40.81%	4,750,769 $369 Million
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $21 Million - $49 Million	290,155 Added 3.75%	8,026,903 $598 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $129 Million - $183 Million	1,025,424 Added 15.28%	7,736,748 $1.32 Billion
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $255 Million - $346 Million	2,006,643 Added 42.65%	6,711,324 $942 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $77.2 Million - $142 Million	829,723 Added 21.41%	4,704,681 $754 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $121 Million - $193 Million	1,465,905 Added 60.85%	3,874,958 $379 Million
Q4 2019 Feb 18, 2020	BUY	$76.53 - $135.58 $184 Million - $327 Million	2,409,053 New	2,409,053 $311 Million

526

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.97B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.